Knockdown of ILK expression also impairs the migration of human umbilical vein ECs (HUVECs) toward VEGF and pharmacological ILK inhibition leads to reduced tumor growth and angiogenesis in a xenograft model21. This evidence concerns the gene ILK and neoplasm.